Lv1
20 积分 2026-05-28 加入
Impact of malignant hypertension on cardiovascular risk and organ damage: what can we learn from the French HAMA registry?
14天前
已完结
Revisiting malignant hypertension: rationale and design of the ‘HAMA cohort’, on behalf of the ESH working group ‘hypertension and the kidney’
16天前
已完结
Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry
17天前
已完结
Nephrosclerosis in young patients with malignant hypertension
17天前
已完结
Revisiting malignant hypertension: rationale and design of the 'HAMA cohort', on behalf of the ESH working group 'hypertension and the kidney'
17天前
已关闭
Malignant Hypertension:A Systemic Cardiovascular Disease
17天前
已完结
Baseline characteristics of the first 302 patients included for acute malignant hypertension crisis in the prospective multidisciplinary HAMA cohort
17天前
已关闭
Nephrosclerosis in young patients with malignant hypertension
18天前
已完结
Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis
1个月前
已完结
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry
1个月前
已完结
皖公网安备34019202002308
